Amgen is one of 3 drugmakers suing the Trump administration. Photo: Al Seib/Los Angeles Times via Getty Images

Amgen, Eli Lilly, Merck and the Association of National Advertisers are suing the Trump administration over its rule forcing pharmaceutical companies to display drugs' list prices in TV commercials. They say the rule violates the First Amendment and exceeds the government's authority.

The big picture: Experts expected drugmakers to file such a lawsuit — even though the new regulation isn't expected to actually affect drug pricing.

What they're saying: The drug companies argue in their complaint that the rule would have a "misleading effect," because the sticker prices would not represent what patients themselves have to pay.

  • The companies also say the regulation violates their First Amendment rights because the government is compelling "commercial speakers to convey the government's preferred messages" without evidence the speech will "advance a substantial government interest."
  • In a separate statement, Amgen said the rule would not address what most patients want to know: what their out-of-pocket costs will be.

Between the lines: The rule itself is pretty small potatoes, but the lawsuit shows the self-interested goals of each party.

  • The Trump administration likes the rule because it's a talking point to say they are doing something about drug prices, despite federal officials admitting it would have negligible effects on patients and drug spending.
  • Pharmaceutical manufacturers don't like the rule because it might discourage patients from buying their products. Instead, the companies like to promote how insured patients can get their drugs for free or at a low cost through drug copay cards — which economists agree raise costs and allow drugmakers to charge higher prices.

The bottom line: Even a minor change like this leads to drug industry opposition.

Go deeper

Updated 7 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Global: Total confirmed cases as of 10 p.m. ET: 30,065,728 — Total deaths: 944,604— Total recoveries: 20,423,802Map
  2. U.S.: Total confirmed cases as of 10 p.m. ET: 6,674,070 — Total deaths: 197,615 — Total recoveries: 2,540,334 — Total tests: 90,710,730Map
  3. Politics: Former Pence aide says she plans to vote for Joe Biden, accusing Trump of costing lives in his coronavirus response.
  4. Health: Pew: 49% of Americans would not get COVID-19 vaccine if available today Pandemic may cause cancer uptick The risks of moving too fast on a vaccine — COVID-19 racial disparities extend to health coverage losses.
  5. Business: Retail sales return to pre-coronavirus trend.
Ina Fried, author of Login
9 hours ago - Technology

Scoop: How the Oracle-TikTok deal would work

Illustration: Aïda Amer/Axios

An agreement between TikTok's Chinese owner ByteDance and Oracle includes a variety of concessions in an effort to make the deal palatable to the Trump administration and security hawks in Congress, according to a source close to the companies.

Driving the news: The deal, in the form of a 20-page term sheet agreed to in principle by the companies, would give Oracle unprecedented access and control over user data as well as other measures designed to ensure that Americans' data is protected, according to the source.

10 hours ago - World

How the EU plans to take on human rights abusers

Illustration: Sarah Grillo/Axios

Amid a global assault on human rights stretching from Belarus to Hong Kong to Yemen, the European Union signaled yesterday that it may act to deter corrupt kleptocrats and state abusers by hitting them where it hurts: their assets.

Driving the news: Europe's chief executive Ursula von der Leyen revealed in her first-ever State of the Union speech that she will bring forth a European Magnitsky Act, a sanctions framework modeled after a U.S. law that restricts malign actors' access to travel and the global financial system.